CHG-2023-0222

Analytical Method Change for Respiralimab. Container Closure Change for Respiralimab — major revision. Impacts 6 markets and 1 variations.

Change Number
CHG-2023-0222
Type
Analytical Method Change
Product
Respiralimab
Status
Blocked
Owner
Carlos Mendez
Initiated
2022-05-07
Description

Container Closure Change for Respiralimab — major revision

Impacted Markets (6)
EU — European UnionGB — United KingdomTW — TaiwanAR — ArgentinaZA — South AfricaPT — Portugal
Impacted Modules
3.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved